FDA Reviewing Psychedelic Drug MDMA to Treat PTSD

Published on June 4, 2024

Federal health advisers are weighing the first-of-a-kind approval of MDMA, the mind-altering club drug, as a treatment for PTSD – part of a decadeslong effort by psychedelic advocates to win medical acceptance for the drug’s purported benefits. The Food and Drug…

Read Full Article (External Site)